Metis Global Partners LLC Raises Stock Holdings in Nutrien Ltd. $NTR

Metis Global Partners LLC lifted its holdings in shares of Nutrien Ltd. (NYSE:NTR) by 5.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 232,686 shares of the company’s stock after purchasing an additional 12,038 shares during the quarter. Metis Global Partners LLC’s holdings in Nutrien were worth $14,362,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Montag A & Associates Inc. boosted its stake in Nutrien by 310.7% in the fourth quarter. Montag A & Associates Inc. now owns 423 shares of the company’s stock worth $26,000 after buying an additional 320 shares in the last quarter. Eastern Bank boosted its stake in Nutrien by 133.0% in the fourth quarter. Eastern Bank now owns 699 shares of the company’s stock worth $43,000 after buying an additional 399 shares in the last quarter. Harbour Investments Inc. boosted its stake in Nutrien by 97.2% in the fourth quarter. Harbour Investments Inc. now owns 704 shares of the company’s stock worth $43,000 after buying an additional 347 shares in the last quarter. Geneos Wealth Management Inc. boosted its stake in Nutrien by 42.4% in the second quarter. Geneos Wealth Management Inc. now owns 735 shares of the company’s stock worth $43,000 after buying an additional 219 shares in the last quarter. Finally, Fulcrum Asset Management LLP purchased a new stake in Nutrien in the third quarter worth approximately $46,000. Hedge funds and other institutional investors own 63.10% of the company’s stock.

Nutrien Stock Performance

Shares of NTR stock opened at $65.05 on Thursday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.59 and a current ratio of 1.24. Nutrien Ltd. has a fifty-two week low of $53.03 and a fifty-two week high of $85.36. The stock has a 50 day moving average price of $71.68 and a two-hundred day moving average price of $69.11. The company has a market capitalization of $31.23 billion, a P/E ratio of 13.25, a PEG ratio of 0.61 and a beta of 0.60.

Nutrien (NYSE:NTR) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.03. Nutrien had a return on equity of 8.84% and a net margin of 8.58%.The firm had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $5.30 billion. During the same quarter in the previous year, the company posted $0.11 earnings per share. The business’s revenue was up 18.5% on a year-over-year basis. Analysts expect that Nutrien Ltd. will post 5.45 earnings per share for the current year.

Nutrien Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 17th. Shareholders of record on Tuesday, June 30th will be given a $0.55 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.20 annualized dividend and a yield of 3.4%. Nutrien’s payout ratio is presently 44.81%.

Analyst Ratings Changes

Several brokerages have issued reports on NTR. Weiss Ratings raised Nutrien from a “hold (c)” rating to a “hold (c+)” rating in a research note on Monday, June 1st. TD Securities reaffirmed a “buy” rating on shares of Nutrien in a research note on Wednesday, May 6th. Jefferies Financial Group raised Nutrien from a “hold” rating to a “buy” rating and upped their target price for the stock from $74.00 to $96.00 in a research note on Thursday, March 12th. UBS Group cut their target price on Nutrien from $67.00 to $65.00 and set a “sell” rating for the company in a research note on Monday, May 11th. Finally, JPMorgan Chase & Co. upped their target price on Nutrien from $78.00 to $80.00 and gave the stock an “overweight” rating in a research note on Monday, May 11th. Eleven research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $81.71.

Nutrien Company Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.